Latham & Watkins represented Portland General Electric Company in the offering, while Davis Polk acted as counsel to the representatives of the underwriters. Portland General Electric Company...
Portland General Electric Company’s $434 Million Common Stock Offering
Amgen’s $3.7 Billion Acquisition of ChemoCentryx
Wachtell, Lipton, Rosen & Katz represented Amgen, while Latham & Watkins represented ChemoCentryx in the transaction. Amgen and ChemoCentryx, Inc., a biopharmaceutical company focused on orally...
Cytokinetics’ $540 Million Convertible Senior Notes Offering
Latham & Watkins represented the initial purchasers in the offering while Cooley advised Cytokinetics. Cytokinetics, Incorporated, a late-stage biopharmaceutical company, has announced the pricing of its...
Sempra Energy’s $1.25 Billion Notes Offering
Latham & Watkins represented Sempra Energy in the offering. Sempra Energy closed its underwritten offering of US$750,000,000 aggregate principal amount of 3.300% Notes due 2025 and US$500,000,000...
Highgate’s assignment of the operation and management of a portfolio of six hotels in Peru
Sandman Savrann and CPB Abogados advised Highgate on the transaction. Greenberg Traurig and Philippi Prietocarrizosa Ferrero DU & Uría advised Inversiones Nacionales de Turismo S.A. (Intursa)...
San Diego Gas & Electric Company’s $1 Billion Bond Offering
Latham & Watkins represented San Diego Gas & Electric Company in the offerings. San Diego Gas & Electric Company, an indirect subsidiary of Sempra Energy, closed...
Southern California Gas Company’s $700 Million Notes Offering
Latham & Watkins represented Southern California Gas Company in the offering. Southern California Gas Company, an indirect subsidiary of Sempra Energy, closed on March 14, 2022 its...
Bionomics’ Initial Public Offering
Latham & Watkins represented Bionomics in the offering. Bionomics Limited, a clinical-stage biopharmaceutical company, has announced the pricing of its initial public offering in the United States...
Connect Biopharma’s $219.9 Million Initial Public Offering
Latham & Watkins LLP and Maples and Calder represented Connect Biopharma in the transaction. Global Law Office and Davis Polk advised joint book-running managers. Connect Biopharma...